Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steris' Isotron Acquisition Adds European Contract Sterilization Services

This article was originally published in The Gray Sheet

Executive Summary

The purchase of contract sterilization and related services firm Isotron gives Steris a foothold in the European market on which to further expand throughout the continent. Announced July 20, the cash deal is valued at $110 mil.

You may also be interested in...



Steris

Allows $110 mil. acquisition offer for U.K.-based Isotron plc to lapse, citing the lack of that firm's shareholder acceptance of the deal, Steris says Aug. 12. First announced July 20, the deal was intended to give Steris a foothold for expansion into the European market (1"The Gray Sheet" July 26, p. 9). Isotron is a provider of sterilization services for single-use medical products. Conditioned on a minimum of 90% Isotron shareholder acceptance of the deal, Steris had received only 60.4% of shareholder acceptances by the Aug. 11 due date. Steris concluded it was "not in the best interests of its shareholders to continue with the offer"

Steris

Allows $110 mil. acquisition offer for U.K.-based Isotron plc to lapse, citing the lack of that firm's shareholder acceptance of the deal, Steris says Aug. 12. First announced July 20, the deal was intended to give Steris a foothold for expansion into the European market (1"The Gray Sheet" July 26, p. 9). Isotron is a provider of sterilization services for single-use medical products. Conditioned on a minimum of 90% Isotron shareholder acceptance of the deal, Steris had received only 60.4% of shareholder acceptances by the Aug. 11 due date. Steris concluded it was "not in the best interests of its shareholders to continue with the offer"

Steris to add contract sterilization services with $142 mil. Isomedix acquisition.

STERIS WOULD ADD CONTRACT STERILIZATION SERVICES WITH $142 MIL. ISOMEDIX BUY announced Aug. 12. The firms have entered a definitive merger agreement that would result in Steris' adding the complementary business of contract sterilization to its line of infection prevention, contamination prevention, and surgical support systems and services. Isomedix provides gamma radiation and ethylene oxide contract sterilization services to manufacturers of pre-packaged medical devices and consumer products.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012094

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel